Hantavirus - More Than Just a Mouse Problem: How to Effectively Protect Yourself and Your Family
An Invisible Companion: Why Hantaviruses Concern Us
The news in May 2026 sounded alarming: An outbreak of hantavirus occurred on the expedition cruise ship “MV Hondius,” which was sailing in the South Atlantic, resulting in three deaths and several other people requiring intensive medical care. Suddenly, a pathogen that many had previously been unfamiliar with was making headlines.
But the alarm raises questions: Is this a new, exotic threat? The clear answer is: No. Hantaviruses are not unknown, especially not in Germany. They have been observed seasonally here for decades, and the Robert Koch Institute (RKI) and local health authorities have extensive knowledge of how to deal with them. The key to staying calm lies in understanding the transmission routes and consistent but simple prevention.
Hantaviruses are a textbook example of zoonoses - pathogens that jump from animals to humans. Their history goes back a long way: the first virus in this family was isolated near Korea's Hantaan River as early as 1976, but Chinese and Russian physicians had described the disease centuries earlier. In Germany, between several dozen and several thousand cases are recorded each year, with major fluctuations depending on weather conditions and the availability of food for rodents. The outbreak on the “MV Hondius” in 2026 was a tragic isolated incident caused by the Andes virus (ANDV), endemic to South America - the only hantavirus proven to be transmissible from person to person. This article provides you with the necessary expert knowledge, dispels myths, and offers practical guidance - based on the latest findings from the RKI, the European Centre for Disease Prevention and Control (ECDC), and the World Health Organization (WHO).
The Pathogen in Detail: What Research Knows Today
The Virus Family: A Global Perspective
Hantaviruses (family Hantaviridae, genus Orthohantavirus) are enveloped RNA viruses with a tripartite, single-stranded genome of negative polarity. This genome encodes three main proteins: an RNA polymerase, a nucleocapsid protein, and a glycoprotein precursor that is cleaved into the two envelope proteins Gn and Gc. Unlike humans, the animal hosts - mainly rodents, but also insectivores and bats - do not become ill themselves, but shed the viruses throughout their lives in high concentrations through saliva, urine, and feces.
The global distribution of hantaviruses follows the distribution of their natural reservoirs. Two clinical syndromes are significant for humans:
- In Eurasia, including Germany, “Old World hantaviruses” cause hemorrhagic fever with renal syndrome (HFRS). Mortality ranges from 1 to 15 percent, depending on the virus type. In Central Europe, a milder form, nephropathia epidemica, predominates.
- In North and South America, “New World hantaviruses” cause hantavirus pulmonary syndrome (HPS) - a severe, often fatal lung disease with a mortality rate of up to 40-50 percent.
In Germany, the Puumala virus (PUUV) is particularly endemic; its reservoir is the bank vole (Myodes glareolus). It is responsible for more than 90 percent of cases reported here. The Dobrava-Belgrade virus (DOBV), transmitted by the striped field mouse (Apodemus agrarius), also occurs in northeastern Germany. The Seoul virus (SEOV), whose host is the brown rat, has a worldwide distribution and has also been detected in Europe. The crucial point is that, according to current knowledge, these virus types found in Germany are not transmissible from person to person. An infected person is not contagious to people around them.
The ANDV exception: What makes the outbreak on the “MV Hondius” special
The tragic incident on the cruise ship was caused by the South American Andes virus (ANDV). This virus is distinctive for several reasons: It causes the highly dangerous hantavirus pulmonary syndrome, with a mortality rate of up to 50 percent. And it is the only known hantavirus that, in rare cases, can be transmitted from person to person through close and prolonged contact.
Human-to-human transmission was first documented in Argentina in 1996 and has since been confirmed in several outbreaks. Studies show that close and prolonged contact - for example, within a household or while caring for sick people - increases the risk. However, transmission efficiency is low: even among household contacts, the secondary attack rate is only around 2-4 percent. By comparison, this figure was many times higher for COVID-19 before the vaccine era.
In its risk assessment from May 2026, the ECDC emphasizes that the natural reservoir for ANDV does not occur in Europe. The establishment of the virus in European rodent populations is therefore not expected. The risk to the general population in the EU from this outbreak is considered very low. Nevertheless, the health authorities in the affected countries have taken extensive precautionary measures, including a six-week quarantine for all passengers after disembarkation.
Routes of infection and disease progression: What happens in the body
The invisible route of transmission
By far the most common route of infection is inhalation of virus-containing aerosols. The viruses can remain infectious in dried dust contaminated with rodent excretions for weeks - and at room temperature and low humidity, even for several months. When sweeping an attic, stacking wood in a shed, or even raking leaves in the garden, these particles can be stirred up and inhaled. Much less frequently, but still possible, infections occur through direct contact with contaminated surfaces followed by touching the mucous membranes, through bites from infected animals, or by consuming contaminated food.
Risk areas in Germany include, in particular, rural and forest-adjacent regions: the Swabian Jura, the Bavarian Forest, the Franconian Jura, the Odenwald, the Münsterland, and the Teutoburg Forest. Most cases occur seasonally between April and September, when people spend more time outdoors and rodent populations become active after winter dormancy. In years with heavy beech mast - that is, a high abundance of tree seeds - the number of bank voles, and therefore the risk of infection, increases significantly.
Symptoms: A deceptive resemblance to the flu
After an incubation period of seven days to six weeks - usually two to four weeks, however - the disease usually begins suddenly with a high fever, chills, and severe headaches, back pain, and pain in the limbs. Nausea, vomiting, and abdominal pain often occur as well. These flu-like symptoms are nonspecific, making diagnosis in the early phase extremely difficult. Visual disturbances, particularly acute myopia (nearsightedness), can be a characteristic early symptom of nephropathia epidemica.
In the second phase of the disease - with the types found in Germany - the clinical picture shifts toward kidney involvement. Acute kidney dysfunction with reduced urine output (oliguria), high blood pressure, and proteinuria may occur. In severe cases, temporary dialysis is necessary. Hemorrhagic diathesis with a tendency to bleed is rare in PUUV infections but occurs more frequently in DOBV infections. Mortality for the European types is below one percent. The American HPS is different: here, the febrile stage is followed by rapidly progressive lung involvement with noncardiogenic pulmonary edema, shortness of breath, and cardiogenic shock, requiring immediate intensive care.
Diagnosis and treatment: What doctors can do
The diagnosis is usually established serologically by detecting specific IgM and IgG antibodies using ELISA or an immunofluorescence test. IgM antibodies can already be detected at the onset of clinical symptoms. In the very early phase of the disease, the viral genome can be directly detected by PCR, but because the viremic phase is short, this is often possible only for a limited time.
No specific antiviral treatment currently exists. Ribavirin, a broad-spectrum antiviral, has shown some effect in certain studies, but is not routinely recommended because of its side effects and conflicting study results. Treatment is purely symptomatic: it ranges from fever-reducing and pain-relieving measures (although nonsteroidal anti-inflammatory drugs such as ibuprofen should be avoided because of the strain they place on the kidneys) to close monitoring of kidney function and intensive care with ventilation and dialysis in severe cases. Seeking medical attention as early as possible is crucial, especially if flu-like symptoms occur after a high-risk activity. The patient should be sure to inform the doctor about possible contact with rodents or their excretions.
Prevention in Practice: Your Shield Against the Virus
Since neither a specific treatment nor an approved vaccine exists, exposure prophylaxis - that is, avoiding contact with the virus - is the only and highly effective protection strategy. It consists of three pillars.
Rodent Management: Preventing Carriers from Gaining Access
The foundation of all prevention is making the human habitat unattractive to mice.
- Seal the building: Inspect the house, basement, attic, garage, and shed for cracks and gaps around doors, windows, and walls. A hole as thick as a pencil is enough for a mouse to enter. Seal these with concrete, steel wool, or special grilles.
- Eliminate food sources: Store pet food, birdseed, seeds, or supplies in closed, preferably rodent-proof containers. Dispose of food scraps and waste in lidded garbage bins and not in the household compost.
- Clear the surroundings: Remove rubbish, woodpiles, and piles of branches near the house, as these serve as hiding places. Keep the immediate surroundings of the house free of dense vegetation. Do not store firewood directly against the house wall.
Hygienic Cleaning and Disinfection: The Essential Rules
The highest risk of infection occurs when cleaning rooms where mice have been present. The most dangerous thing for allergy sufferers is simply sweeping with a broom or using a vacuum cleaner. This massively stirs up contaminated dust and distributes it through the indoor air. The ECDC also recommends consistent cleaning and disinfection measures for healthcare personnel who come into contact with suspected cases.
Step-by-step guide to safe cleaning:
- Ventilate: Open windows and doors before starting work and ventilate the room thoroughly for at least 30 minutes.
- Put on protective clothing: Put on disposable gloves and a protective mask.
- Moisten, do not sweep: Generously spray visible rodent droppings, dead animals, or nests with a suitable disinfectant. Allow the product to work for sufficient time (at least 5-10 minutes, depending on the manufacturer's instructions). The aim is to soak the dust and dried excrement and inactivate the virus.
- Collecting and final cleaning: Wipe up the soaked areas with paper towels or a cloth and dispose of both in a tightly sealed plastic bag with household waste. Then thoroughly clean the affected surfaces with a special surface disinfectant according to the instructions for use.
- Alternatively: For smooth surfaces, a solution of standard household bleach (sodium hypochlorite) at a ratio of 1:10 (one part bleach, nine parts water) is also effective. For more sensitive surfaces or electronic devices, an alcohol-based disinfectant is recommended, such as highly concentrated isopropyl alcohol (99.9%), which evaporates without leaving any residue. However, larger areas should not be soaked with alcohol in an enclosed room; ensure good ventilation and observe fire safety precautions.
- After cleaning: Remove and dispose of the gloves. Wash your hands thoroughly with soap and water. The clothing worn should be washed immediately.
Important: Use this method for dead mice and their nests as well. Spray them first, then dispose of them without touching them directly. Always wear gloves when doing so.
Respiratory protection: Choosing the right mask for protection
Not every mask protects against viruses. Cloth masks (fabric face coverings) or surgical masks (surgical masks) are primarily designed to protect others by capturing the wearer's droplets. They do not provide sufficient protection against inhaling the smallest virus-containing aerosols, such as those produced when rodent dust is stirred up. The ECDC also explicitly recommends that medical personnel wear FFP2 respirators when caring for suspected ANDV cases.
The only effective protection is a particulate-filtering half mask. In the EU, these must be tested according to the EN 149 standard and fall into the FFP2 or FFP3 classes. Their fit creates a tight seal against the face, and they filter out at least 94 percent (FFP2) or 99 percent (FFP3) of airborne particles up to 0.6 μm in size. Although hantaviruses themselves are smaller, measuring approximately 80–120 nm in diameter, they generally adhere to larger dust particles, which are effectively retained by FFP masks.
For activities involving heavy dust generation, such as in old sheds or barns, an FFP3 mask is recommended. Please ensure a proper fit without leaks, especially at the sides and around the nose bridge. Unobstructed breathing must be possible. A suitable and tested range of FFP2/FFP3 masks provides safety in all situations. People with beards or certain face shapes should check the seal, as this can impair filtration performance.
Vaccine research: A glimmer of hope on the horizon
The good news is that science is not standing still. The lack of a vaccine is a known problem that is being addressed intensively around the world.
In Germany and Europe, Puumala virus predominates, but vaccine research is targeting several hantavirus types simultaneously. An international research team at the University of Bath is working on a novel vaccine candidate that uses both mRNA technology and a groundbreaking stabilization method called “ensilication” - the active vaccine components are enclosed in protective silica shells, eliminating the need for refrigeration. Preclinical tests have shown excellent immune responses.
Particularly promising: A study published in Nature Communications in March 2026 demonstrated a sophisticated structure-based approach. Researchers developed a genetically stabilized glycoprotein antigen from Hantaan virus, fixed in a prefusion-stabilized conformation. Administered as both a DNA and an mRNA vaccine, it triggered strong and long-lasting production of neutralizing antibodies and protected mice against a lethal dose of hantavirus. The antibodies produced in this way remained at high levels for months, while antibody levels rapidly declined after administration of the conventional inactivated vaccine.
Research is also being conducted on a universal vaccine that protects against several hantavirus types simultaneously. In South Korea, the Vaccine Innovation Center at Korea University successfully tested an mRNA vaccine against Hantaan and Seoul viruses in animal trials, with the aim of bringing it into phase 1 clinical trials by 2028. A universal vaccine that also covers Andes virus is in the early stages of research. In the United States, a DNA vaccine against Andes virus has already been tested in a phase 1 study involving 48 healthy adults - more than 80 percent of those vaccinated retained protective antibody levels for 337 days.
Nevertheless: It will still be several years before a vaccine is generally available. The rarity and geographical dispersion of cases make large-scale phase 3 efficacy studies difficult, and reliable surrogate markers for accelerated approval procedures are still lacking.
At the same time, European health authorities are focusing on surveillance. During the 2026 ANDV outbreak, the European Centre for Disease Prevention and Control (ECDC) promptly published a threat assessment report and sent an expert from the EU Health Task Force to the affected cruise ship. The EU Health Security Committee (HSC) coordinated the repatriation and quarantine of the passengers. The risk to the general population in the EU is classified as very low by the ECDC.
Through the season with knowledge and composure
Hantaviruses are part of our environment, and they will remain so. The outbreak on the “MV Hondius” mentioned at the beginning was a tragic isolated incident caused by the specific characteristics of a virus type not found in Germany. The German authorities, led by the RKI, have emphasized for years, and continue to emphasize today: There is no reason to panic. The risk to the general population is low and can be controlled almost completely through prudent behavior.
Protection is not a matter of luck, but of knowledge and proper preparation. Anyone who takes the necessary care in high-risk areas and during high-risk months, wears an FFP2/FFP3 mask, and follows the simple cleaning rules can effectively protect themselves and their family. Vaccine research is making significant progress - from mRNA platforms and DNA vaccines to universal approaches. Until these are ready for the market, however, consistent prophylaxis remains our best protection. Use information from reputable sources such as the Robert Koch Institute to stay up to date. Enter the gardening season informed and prepared - and enjoy nature without unnecessary worry.
